TriCore Announces Dr. Michael Crossey as Chief Executive Officer & President


Albuquerque, NM, March 06, 2018 (GLOBE NEWSWIRE) --

TriCore Contact:

Dr. Nick Dayan

Chief Administrative Officer

(505) 938-8991

Nicholas.Dayan@tricore.org

 

TriCore Announces Dr. Michael Crossey as Chief Executive Officer & President

 

For Immediate Release (Albuquerque, New Mexico) - March 6, 2018 – TriCore Reference Laboratories is pleased to announce that the board of directors has appointed Michael Crossey, MD, PhD, to the position of CEO and president, effective immediately.

Dr. Crossey’s appointment is a clear reflection of the company’s current state: Ready to take on the future!  Robin Divine, chair of TriCore’s board of directors, stated: “Enormous opportunity for TriCore lies ahead.  We couldn’t be happier with Dr. Crossey accepting this position and moving us down the path of continued success.”

For the past 20 years since TriCore’s inception, Dr. Crossey has served the organization in various capacities, from pathologist to chief medical officer to interim chief executive officer.  He brings decades of experience and internationally recognized expertise in clinical laboratory medicine to the company.

Says Dr. Crossey of his new position: “I'm honored, and I'm grateful to the board for the opportunity to lead this exceptional organization of creative, dedicated and talented professionals."

###

 

 

TriCore Reference Laboratories is an independent, not-for-profit, clinical reference laboratory founded and headquartered in Albuquerque, New Mexico, co-sponsored by Presbyterian Healthcare Services and University of New Mexico Health Sciences Center. TriCore provides over 2,900, full-service, state-of-the-art laboratory tests to healthcare professionals and their patients. TriCore also provides analytics and research services, supporting healthcare and scientific organizations worldwide. 

For more information, visit tricore.org.

Attachment:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/68207f80-51fb-4664-84de-80bee403f3fc


            

Contact Data